About Us

AbGenomics International Inc. is a clinical-stage biopharmaceutical company headquartered in the San Francisco Bay Area focused on developing novel best-in-class therapeutics for inflammatory/autoimmune diseases and cancers. Learn more

Pipeline Highlights

View full chart